StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) stock

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$25.57+1.34 (+5.53%)

Close on Nov 18, 2026Market cap $2.06BP/E 18.3Yield –

Veracyte market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Veracyte's market cap was $2.02B on Nov 11, 2026, against $3.74B a year earlier. Over the last 5 years it ranged from $1.19B to $4.69B, with a median of $2.01B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.02B-39.4%
2025Dec 31, 2025$3.33B+8.4%
2024Dec 31, 2024$3.07B+52.8%
2023Dec 29, 2023$2.01B+18.0%
2022Dec 30, 2022$1.70B-41.8%
2021Dec 31, 2021$2.93B+3.4%
2020Dec 31, 2020$2.83B+107.6%
2019Dec 31, 2019$1.36B+167.3%
2018Dec 31, 2018$509.94M+129.8%
2017Dec 29, 2017$221.88M+2.6%
2016Dec 30, 2016$216.26M+8.6%
2015Dec 31, 2015$199.13M-8.3%
2014Dec 31, 2014$217.26M+1409.5%
2013Dec 31, 2013$14.39M–

More Veracyte figures

See a number that looks wrong?